Molecule drug discovery company Kesmalea has secured a new hub in Hammersmith, W6.
The firm, which is backed by Syncona, Oxford Science Enterprises and BioInnovation Institute, has agreed a five-year lease with a break option at year three in the
Thank you for reading EG
Want to read more? Enjoy a story a week for FREE for one month.
